{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:41:56Z","timestamp":1760820116174},"reference-count":41,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,2,8]],"date-time":"2009-02-08T00:00:00Z","timestamp":1234051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The aim of the study was to evaluate long\u2010term changes in lipids and to assess other coronary heart disease (CHD) risk factors in highly experienced AIDS patients with immune reconstitution, and to examine their association with antiretroviral therapy (ART).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We evaluated 433 AIDS patients with prior severe immunosuppression and ART\u2010based immune reconstitution, followed in a multicentre prospective observational study between 2000 and 2006. We estimated the prevalence at entry of hypercholesterolaemia and metabolic syndrome, and 10\u2010year CHD risks. Trends in total cholesterol (TC), triglycerides (TG) and high\u2010density lipoprotein (HDL) cholesterol were evaluated over time, and use of specific ART drugs at each study visit was assessed using mixed effect models, adjusting for CHD risk factors and use of lipid\u2010lowering agents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At entry to observational follow\u2010up, 28% of the 433 subjects had hypercholesterolaemia and 15% had a predicted 10\u2010year CHD risk above 20%. Average TC and fasting TG levels declined over the follow\u2010up period (median=5.8 years), and these declines were associated with increased use of physician\u2010prescribed lipid\u2010lowering agents and changes in ART regimens. After adjustment for CHD risk factors, TC and TG levels were significantly higher for those on ritonavir\u2010boosted protease inhibitors and those on nonnucleoside reverse transcriptase inhibitors (NNRTIs), particularly efavirenz, than for other patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Abnormalities in serum lipids were common at baseline but became less so over time, and this improvement was associated with increased use of lipid\u2010lowering agents and selection of ART agents with less deleterious effects on lipids.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2008.00685.x","type":"journal-article","created":{"date-parts":[[2009,2,9]],"date-time":"2009-02-09T02:15:06Z","timestamp":1234145706000},"page":"290-301","source":"Crossref","is-referenced-by-count":13,"title":["Improvement in lipid profiles over 6 years of follow\u2010up in adults with AIDS and immune reconstitution"],"prefix":"10.1111","volume":"10","author":[{"given":"PL","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JW","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SE","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SL","family":"Koletar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JA","family":"McCutchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RL","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JS","family":"Currier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the AIDS Clinical Trials Group 362 Study Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,16]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200011100-00001"},{"key":"e_1_2_6_3_2","first-page":"329","article-title":"Premature atherosclerosis in HIV\u2010infected individuals","volume":"15","author":"Depairon M","year":"2001","journal-title":"focus on protease inhibitor therapy"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/317541"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041811"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2007.00537.x"},{"key":"e_1_2_6_8_2","first-page":"1179","article-title":"Cardiovascular disease risk factors in HIV patients \u2013 association with antiretroviral therapy","volume":"17","author":"Friis\u2010M\u00f8ller N","year":"2003","journal-title":"results from the DAD Study"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan K","year":"2000","journal-title":"J Acquir Immun Defic Syndr"},{"key":"e_1_2_6_10_2","first-page":"1056","article-title":"Lipid profiles in HIV\u2010infected patients receiving combination antiretroviral therapy","volume":"189","author":"Fontas E","year":"2004","journal-title":"are different drugs associated with different lipid profiles?"},{"key":"e_1_2_6_11_2","first-page":"585","article-title":"Lipid profiles for antiretroviral\u2010na\u00efve patients starting PI\u2010 and NNRTI\u2010based therapy in the Swiss HIV Cohort Study","volume":"20","author":"Young J","year":"2005","journal-title":"Antivir Ther"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31804216cf"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020794"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2005.00333.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.22.2978"},{"key":"e_1_2_6_16_2","first-page":"844","article-title":"Metabolic and skeletal complications of HIV infection","volume":"296","author":"Morse CG","year":"2006","journal-title":"the price of success"},{"key":"e_1_2_6_17_2","first-page":"114","article-title":"Effects of HIV disease on lipid, glucose and insulin levels","volume":"6","author":"El\u2010Sadr WM","year":"2005","journal-title":"results from a large antiretroviral-na\u00efve cohort"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.7.700"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200001070-00006"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1310\/VHBA-X9FE-YRQR-YVBK"},{"key":"e_1_2_6_21_2","first-page":"800","article-title":"Lipid disorders in antiretroviral\u2010na\u00efve patients treated with lopinavir\/ritonavir\u2010based HAART","volume":"55","author":"Montes ML","year":"2005","journal-title":"frequency, characterization and risk factors"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-4-4"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200403260-00017"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200501010-00009"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200112070-00008"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0010019"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000166091.39317.99"},{"key":"e_1_2_6_28_2","first-page":"85","article-title":"A prospective, 96\u2010week study of the impact of trizivir, combivir\/nelfinavir, and lamivudine\/stavudine\/nelfinavir on lipids, metabolic parameters, and efficacy in antiretroviral\u2010na\u00efve patients","volume":"7","author":"Kumar PN","year":"2006","journal-title":"effect of sex and ethnicity"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062744"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200311210-00010"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79053-X"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200012010-00021"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200208150-00002"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11672-2"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-7-200010030-00008"},{"key":"e_1_2_6_36_2","unstructured":"National Cholesterol Education Program (NCEP): Third report of the Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication No. 01\u20103670."},{"volume-title":"Linear Mixed Models for Longitudinal Data","year":"2000","author":"Verbeke G","key":"e_1_2_6_37_2"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/424882"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/368185"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/528862"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318164227f"},{"key":"e_1_2_6_42_2","unstructured":"Friis\u2010MollerN ThiebautR ReissPfor the D:A:D Study Group.Predicting the risk of coronary heart disease in HIV\u2010infected patients. The D:A:D risk equation.14th Conference on Retroviruses and Opportunistic Infections. Los Angeles CA February 2007 [Abstract 808]."}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2008.00685.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2008.00685.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:37:56Z","timestamp":1696865876000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2008.00685.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,16]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1468-1293.2008.00685.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2008.00685.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"type":"print","value":"1464-2662"},{"type":"electronic","value":"1468-1293"}],"subject":[],"published":{"date-parts":[[2009,4,16]]}}}